Rankings
▼
Calendar
CYTK Q3 2019 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
CYTK
Cytokinetics, Incorporated
$8B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
-43.1% YoY
Gross Profit
-$14M
-234.1% margin
Operating Income
-$24M
-395.2% margin
Net Income
-$30M
-488.4% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
-15.2%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$187M
Total Liabilities
$207M
Stockholders' Equity
-$20M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$11M
-43.1%
Gross Profit
-$14M
-$11M
-31.9%
Operating Income
-$24M
-$18M
-33.6%
Net Income
-$30M
-$22M
-34.3%
Revenue Segments
Research And Development
$6M
100%
← FY 2019
All Quarters
Q4 2019 →